Page last updated: 2024-10-18

dihydroxyphenylalanine and Behavior Disorders

dihydroxyphenylalanine has been researched along with Behavior Disorders in 66 studies

Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.

Research Excerpts

ExcerptRelevanceReference

Research

Studies (66)

TimeframeStudies, this research(%)All Research%
pre-199063 (95.45)18.7374
1990's0 (0.00)18.2507
2000's1 (1.52)29.6817
2010's2 (3.03)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pretze, M1
Wängler, C1
Wängler, B1
Capuron, L1
Pagnoni, G1
Drake, DF1
Woolwine, BJ1
Spivey, JR1
Crowe, RJ1
Votaw, JR1
Goodman, MM1
Miller, AH1
TRUITT, EB1
EBERSBERGER, EM1
SCHULTE, W1
Gorman, JM1
Sabelli, HC1
Mosnaim, AD1
Vazquez, AJ1
Giardina, WJ1
Borison, RL1
Pedemonte, WA1
Nemeroff, CB1
Loosen, PT1
Bissette, G1
Manberg, PJ1
Wilson, IC1
Lipton, MA1
Prange, AJ1
Gehlen, W1
Gonce, M1
Barbeau, A2
Campbell, KM1
Wade, D1
Ross, LW1
Meyer, GG1
Hunter, KR1
Stern, GM2
Sharkey, J1
Tan, BK1
Leijnse-Ybema, HJ1
v d Brand, HJ1
Botez, MI1
Calne, DB2
Spiers, AS1
Laurence, DR1
Hällström, T1
Persson, T2
Jenkins, RB1
Groh, RH1
Sacks, OW2
Kohl, M1
Bird, MT1
Paulson, GW1
Schnur, JA2
Chase, TN1
Brody, JA2
Constantinidis, J1
Van Woert, MH1
Ambani, LM1
Levine, RJ1
Vinar, O1
Wyatt, RJ1
Reid, JL1
Mones, RJ1
Julsrud, OJ1
Horvath, TB1
Meares, RA1
Boudin, G2
Pépin, B2
Guillard, A3
Fabiani, JM1
Haguenau, M1
Völler, GW1
Muschard, F1
Murphy, DL1
Rinne, UK2
Stancer, HC1
Sathananthan, G1
Angrist, BM1
Gershon, S1
Vogt, M1
Rosati, G1
Agnetti, V1
Mura, F1
Granieri, E1
Presthus, J1
Holmsen, R1
Celesia, GG1
Wanamaker, WM1
Lhermitte, F2
Degos, CF1
Kohl, MS1
Messeloff, CR1
Schwartz, WF1
Cole, JO1
Shapiro, SK1
Lehmann, J1
Almici, GM1
Sbarbaro, V1
Rysánek, K1
Kaeser, HE1
Ferel, D1
Wurmser, P1
Knopp, W1
Castaigne, P1
Beck, H1
Marteau, R1
Rondot, P1
Raphy, B1
Sonninen, V1
Siirtola, T1
Klawans, HL2
McKendall, RR1
Newkirk, TA1
Magee, KR1
Chase, RN1
Gordon, EK1
Longo, V1
Kemali, D1
Pacini, A1
Bertolino, A1
Lamura, G1
Goodwin, FK1
Inanaga, K1
Oshima, M1
Tachibana, H1
Nakamura, K1
Koketsu, K1
Ginath, Y1
Lavy, S1
Abramsky, O1
Carmon, A1
Garvin, JS1
Bonduelle, M1
Wålinder, J1
Jelsma, F1
Roth, R1
Ross, P1
Davis, J1

Reviews

12 reviews available for dihydroxyphenylalanine and Behavior Disorders

ArticleYear
6-[18F]fluoro-L-DOPA: a well-established neurotracer with expanding application spectrum and strongly improved radiosyntheses.
    BioMed research international, 2014, Volume: 2014

    Topics: Brain Neoplasms; Dihydroxyphenylalanine; Humans; Mental Disorders; Movement Disorders; Radioactive T

2014
Biochemical plasticity of synaptic transmission: a critical review of Dale's Principle.
    Biological psychiatry, 1976, Volume: 11, Issue:4

    Topics: 5-Hydroxytryptophan; Animals; Brain; Carbidopa; Deamination; Dihydroxyphenylalanine; Evoked Potentia

1976
Pharmaco-behavioral effects of hypothalamic peptides in animals and man: focus on thyrotropin-releasing hormone and neurotensin.
    Psychoneuroendocrinology, 1978, Volume: 3, Issue:3-4

    Topics: Animals; Behavior, Animal; Body Temperature; Brain; Dihydroxyphenylalanine; Drug Synergism; Humans;

1978
[Iatrogenic damage possibilities in the drug therapy of neurologic and psychiatric diseases].
    Medizinische Klinik, 1977, Aug-12, Volume: 72, Issue:32-33

    Topics: Amantadine; Anticonvulsants; Barbiturates; Benzodiazepines; Carbamazepine; Central Nervous System Di

1977
[The current treatment of Parkinson's disease].
    Revue medicale de Liege, 1976, Oct-10, Volume: 31, Issue:19

    Topics: Amantadine; Antidepressive Agents, Tricyclic; Dihydroxyphenylalanine; Drug Combinations; Histamine A

1976
[Clinical psychopharmacology in 1971].
    Activitas nervosa superior, 1972, Volume: 14, Issue:2

    Topics: Amphetamine; Antidepressive Agents; Antiparkinson Agents; Chemical Phenomena; Chemistry; Chlorpromaz

1972
Antiparkinsonian drugs: pharmacological and therapeutic aspects.
    Drugs, 1972, Volume: 4, Issue:1

    Topics: Acetylcholine; Adrenergic beta-Antagonists; Amantadine; Amphetamine; Antiparkinson Agents; Apomorphi

1972
Mental effects of L-dopa.
    Annual review of medicine, 1973, Volume: 24

    Topics: Affective Symptoms; Behavior; Cognition; Dihydroxyphenylalanine; Dopamine; Humans; Learning; Memory;

1973
Recent advances in the treatment of Parkinsonism with drugs.
    Acta neurologica Scandinavica. Supplementum, 1972, Volume: 51

    Topics: Amantadine; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Arrhythmias, Cardiac; Blood-Brain

1972
Psychopharmacology. Yesterday, today and tomorrow: a point of view.
    Canadian Psychiatric Association journal, 1973, Volume: 18, Issue:5

    Topics: Affective Symptoms; Amitriptyline; Antidepressive Agents; Canada; Carbonates; Depression; Dihydroxyp

1973
Functional aspects of the role of catecholamines in the central nervous system.
    British medical bulletin, 1973, Volume: 29, Issue:2

    Topics: Animals; Brain; Catecholamines; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Epinephrine; Huma

1973
[Relation of monoamines to mental disorders].
    Activitas nervosa superior, 1970, Volume: 12, Issue:2

    Topics: Amines; Animals; Bipolar Disorder; Catecholamines; Central Nervous System; Depression; Dihydroxyphen

1970

Trials

8 trials available for dihydroxyphenylalanine and Behavior Disorders

ArticleYear
L-dopa in idiopathic parkinsonism.
    Lancet (London, England), 1969, Nov-08, Volume: 2, Issue:7628

    Topics: Clinical Trials as Topic; Dihydroxyphenylalanine; Humans; Hypotension, Orthostatic; Mental Disorders

1969
Clinical effects of para-chlorophenylalanine in Parkinson's disease.
    Diseases of the nervous system, 1972, Volume: 33, Issue:12

    Topics: Aged; Benztropine; Brain; Clinical Trials as Topic; Depression; Dihydroxyphenylalanine; Evaluation S

1972
The serotonin-catecholamine-dream bicycle: a clinical study.
    Biological psychiatry, 1972, Volume: 5, Issue:1

    Topics: 5-Hydroxytryptophan; Aged; Brain; Brain Chemistry; Catecholamines; Clinical Trials as Topic; Dihydro

1972
Response threshold to levodopa in psychiatric patients.
    Biological psychiatry, 1973, Volume: 7, Issue:2

    Topics: Adult; Brain Chemistry; Clinical Trials as Topic; Cognition Disorders; Dihydroxyphenylalanine; Dopam

1973
[Treatment of Parkinsonic syndrome with levo-Dopa. Case reports].
    Minerva medica, 1974, May-02, Volume: 65, Issue:33

    Topics: Arteriosclerosis; Clinical Trials as Topic; Dihydroxyphenylalanine; Drug Evaluation; Female; Humans;

1974
Psychiatric changes in patients treated with levodopa. I. The clinical experiment.
    Neurology, 1970, Volume: 20, Issue:12

    Topics: Activities of Daily Living; Adjustment Disorders; Aged; Amitriptyline; Clinical Trials as Topic; Dia

1970
[Treatment of Parkinson's disease with L-dopa. 77 cases].
    Revue neurologique, 1970, Volume: 122, Issue:2

    Topics: Adult; Age Factors; Aged; Cardiovascular Diseases; Clinical Trials as Topic; Dihydroxyphenylalanine;

1970
L-Dopa treatment in Parkinson's Disease.
    European neurology, 1970, Volume: 4, Issue:6

    Topics: Age Factors; Anorexia Nervosa; Cardiovascular Diseases; Clinical Trials as Topic; Dihydroxyphenylala

1970

Other Studies

46 other studies available for dihydroxyphenylalanine and Behavior Disorders

ArticleYear
Dopaminergic mechanisms of reduced basal ganglia responses to hedonic reward during interferon alfa administration.
    Archives of general psychiatry, 2012, Volume: 69, Issue:10

    Topics: Adult; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Female; Hepatitis C, Chronic; Humans; Inte

2012
Decarboxylase inhibitors affect convulsion thresholds to hexafluorodiethyl ether.
    Science (New York, N.Y.), 1962, Jan-12, Volume: 135, Issue:3498

    Topics: Amines; Animals; Brain; Carboxy-Lyases; Dihydroxyphenylalanine; Ether; Lyases; Mental Disorders; Mic

1962
[PSYCHIATRIC UNIVERSITY CLINIC AND PSYCHIATRIC STATE HOSPITAL].
    Deutsche medizinische Wochenschrift (1946), 1964, Oct-30, Volume: 89

    Topics: Aging; Brain Diseases; Dihydroxyphenylalanine; Germany; Germany, West; Hospitals, Psychiatric; Hospi

1964
More to movement disorders than motion.
    CNS spectrums, 2006, Volume: 11, Issue:7

    Topics: Basal Ganglia; Deep Brain Stimulation; Dihydroxyphenylalanine; Humans; Mental Disorders; Movement Di

2006
[Cerebral amines].
    Nihon rinsho. Japanese journal of clinical medicine, 1976, Sep-10, Volume: 34, Issue:9

    Topics: Amines; Animals; Brain; Dihydroxyphenylalanine; Haplorhini; Humans; Mental Disorders; Mice; Neurons;

1976
Pigmentation and musculoskeletal abnormalities in an aged state hospital population.
    Journal of the American Geriatrics Society, 1977, Volume: 25, Issue:9

    Topics: Adult; Aged; Bone Diseases; Dihydroxyphenylalanine; Female; Humans; Male; Melanins; Melatonin; Menta

1977
Levodopa in postencephalitic parkinsonism.
    Lancet (London, England), 1970, Dec-26, Volume: 2, Issue:7687

    Topics: Dihydroxyphenylalanine; Humans; Mental Disorders; Movement Disorders; Parkinson Disease, Postencepha

1970
L-dopa. II.
    British medical journal, 1970, Nov-28, Volume: 4, Issue:5734

    Topics: Anorexia Nervosa; Cardiac Complexes, Premature; Dihydroxyphenylalanine; Drug Synergism; Humans; Hypo

1970
Levodopa in Huntington's chorea.
    Lancet (London, England), 1972, Apr-22, Volume: 1, Issue:7756

    Topics: Chlorpromazine; Dihydroxyphenylalanine; Female; Humans; Huntington Disease; Mental Disorders; Middle

1972
Letter: Long term mental changes in levodopa-treated patients.
    Lancet (London, England), 1973, Nov-03, Volume: 302, Issue:7836

    Topics: Dihydroxyphenylalanine; Follow-Up Studies; Humans; Intelligence Tests; Mental Disorders; Mental Proc

1973
L-dopa and non-emission of semen.
    Lancet (London, England), 1970, Jun-06, Volume: 1, Issue:7658

    Topics: Adult; Dihydroxyphenylalanine; Ejaculation; Female; Humans; Male; Mental Disorders; Middle Aged; Sem

1970
Mental symptoms in Parkinsonian patients treated with L-dopa.
    Lancet (London, England), 1970, Jul-25, Volume: 2, Issue:7665

    Topics: Aged; Behavior; Depression; Dihydroxyphenylalanine; Dreams; Female; Humans; Imipramine; Male; Memory

1970
L-dopa and oculogyric crises.
    Lancet (London, England), 1970, Jul-25, Volume: 2, Issue:7665

    Topics: Catalepsy; Dihydroxyphenylalanine; Encephalitis, Arbovirus; Eye; Humans; Mental Disorders

1970
Early onset rigid Huntington's disease.
    Neurology, 1970, Volume: 20, Issue:4

    Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Diagnosis, Differential; Dihydroxyphenylalanine; E

1970
Parkinsonism-dementia of Guam: treatment with L-dopa.
    Neurology, 1971, Volume: 21, Issue:12

    Topics: Adult; Dementia; Dihydroxyphenylalanine; Drug Eruptions; Female; Humans; Hydroxyindoleacetic Acid; H

1971
[Monoamines and choreic syndromes].
    Revue neurologique, 1972, Volume: 127, Issue:1

    Topics: Amines; Butyrophenones; Chorea; Diazepam; Dihydroxyphenylalanine; Dopamine; Ganglia; Globus Pallidus

1972
Parkinson's disease treated with L-dopa. Three-year follow-up report.
    New York state journal of medicine, 1972, Nov-15, Volume: 72, Issue:22

    Topics: Dihydroxyphenylalanine; Follow-Up Studies; Humans; Mental Disorders; Movement Disorders; Nausea; Par

1972
Treatment failures with L-dopa in Parkinsonism.
    Acta neurologica Scandinavica. Supplementum, 1972, Volume: 51

    Topics: Adult; Aged; Dihydroxyphenylalanine; Female; Gastrointestinal Diseases; Humans; Intracranial Arterio

1972
The relevance of the neurophysiological concepts of excitation and inhibition to clinical psychiatry.
    The Australian and New Zealand journal of psychiatry, 1973, Volume: 7, Issue:2

    Topics: Acoustic Stimulation; Adolescent; Adult; Aged; Alcohol Amnestic Disorder; Anxiety; Arousal; Dihydrox

1973
[Indications and results of monoamine treatment in parkinsonian syndromes].
    Revue neurologique, 1972, Volume: 127, Issue:1

    Topics: Aged; Arrhythmias, Cardiac; Benserazide; Carboxy-Lyases; Dihydroxyphenylalanine; Drug Combinations;

1972
Efficacy of and possible differences in tolerance to L-dopa tablets with different rates of release of the active substance.
    Acta neurologica Scandinavica, 1974, Volume: 50, Issue:3

    Topics: Administration, Oral; Arrhythmias, Cardiac; Dihydroxyphenylalanine; Drug Tolerance; Feeding and Eati

1974
[Long-term treatment of Parkinsonism with L-dopa].
    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1972, Nov-30, Volume: 92, Issue:33

    Topics: Adult; Aged; Anorexia Nervosa; Dihydroxyphenylalanine; Female; Humans; Long-Term Care; Male; Mental

1972
Psychiatric disturbances in Parkinson's disease.
    Diseases of the nervous system, 1972, Volume: 33, Issue:9

    Topics: Adult; Aged; Barbiturates; Cognition Disorders; Depression; Dihydroxyphenylalanine; Female; Follow-U

1972
[Treatment of Parkinson syndromes with L-Dopa and the association of L-Dopa and a decarboxylase inhibitor].
    Bruxelles medical, 1972, Volume: 52, Issue:10

    Topics: Aged; Arrhythmias, Cardiac; Carboxy-Lyases; Dihydroxyphenylalanine; Drug Synergism; Female; Gastroin

1972
[Drug therapy of Parkinson's diseases].
    Acquisitions medicales recentes, 1972

    Topics: Amantadine; Dihydroxyphenylalanine; Gastrointestinal Diseases; Humans; Hypotension, Orthostatic; Men

1972
Effects of levodopa in Parkinsonian patients with dementia.
    Neurology, 1972, Volume: 22, Issue:5

    Topics: Aged; Delirium; Dihydroxyphenylalanine; Evaluation Studies as Topic; Female; Humans; Male; Mental Di

1972
The impact of scientific models on clinical psychopharmacology: a psychiatrist's view.
    Seminars in psychiatry, 1972, Volume: 4, Issue:3

    Topics: Antidepressive Agents; Anxiety Disorders; Attitude of Health Personnel; Behavior Therapy; Brain; Con

1972
Hypersexual behavior complicating levodopa (I-dopa) therapy.
    Minnesota medicine, 1973, Volume: 56, Issue:1

    Topics: Aged; Dihydroxyphenylalanine; Erectile Dysfunction; Humans; Male; Mental Disorders; Parkinson Diseas

1973
Levodopa and related drugs.
    The Medical letter on drugs and therapeutics, 1973, Mar-02, Volume: 15, Issue:5

    Topics: Amantadine; Apomorphine; Dihydroxyphenylalanine; Humans; Hydrazines; Hypotension; Mental Disorders;

1973
Psychiatric complications of medical drugs.
    The Medical journal of Australia, 1973, Jun-30, Volume: 1, Issue:26

    Topics: Adrenal Cortex Hormones; Digitalis Glycosides; Dihydroxyphenylalanine; Drug-Related Side Effects and

1973
Tryptophan malabsorption in levodopa-treated parkinsonian patients. Effect of tryptophan on mental disturbances.
    Acta medica Scandinavica, 1973, Volume: 194, Issue:3

    Topics: Aged; Brain; Dementia; Depression, Chemical; Dihydroxyphenylalanine; Female; Humans; Hydroxyindoleac

1973
[Case reports of some mental disorders in parkinsonian patients treated with L-dopa].
    Minerva medica, 1974, Feb-03, Volume: 65, Issue:8

    Topics: Aged; Anxiety Disorders; Cognition Disorders; Depression; Dihydroxyphenylalanine; Female; Hallucinat

1974
Editorial: Mental changes in Parkinsonism.
    British medical journal, 1974, Apr-06, Volume: 2, Issue:5909

    Topics: Brain; Dihydroxyphenylalanine; Humans; Mental Disorders; Parkinson Disease

1974
[Treatment of Parkinson's syndrome with L-dopa].
    Schweizerische medizinische Wochenschrift, 1970, May-09, Volume: 100, Issue:19

    Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Antihypertensive Agents; Barbiturates;

1970
Observations on the effect of levodopa on tardive lingual-facial-buccal dyskinesia.
    Journal of the neurological sciences, 1971, Volume: 14, Issue:2

    Topics: Aged; Chlorpromazine; Dihydroxyphenylalanine; Dopamine; Facial Muscles; Female; Haloperidol; Humans;

1971
Treatment of parkinsonism with levo-dopa: results in 302 cases.
    Michigan medicine, 1971, Volume: 70, Issue:22

    Topics: Aged; Dihydroxyphenylalanine; Female; Follow-Up Studies; Gastrointestinal Diseases; Humans; Hypotens

1971
Parkinsonism-dementia and amyotrophic lateral sclerosis of Guam. Effect of probenecid on monoamine catabolite levels in cerebrospinal fluid.
    Archives of neurology, 1971, Volume: 25, Issue:1

    Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Dihydroxyphenylalanine; Dopamine; Female; Humans; Hydrox

1971
[Evaluation in clinical trials of some drug associations. (L-dopa, neuroleptics and lithium carbonate)].
    Bollettino della Societa italiana di biologia sperimentale, 1971, Aug-15, Volume: 47, Issue:15

    Topics: Basal Ganglia Diseases; Dihydroxyphenylalanine; Extrapyramidal Tracts; Humans; Lithium; Mental Disor

1971
Behavioral effects of l-dopa in man.
    Seminars in psychiatry, 1971, Volume: 3, Issue:4

    Topics: Adult; Aged; Cerebral Cortex; Cognition Disorders; Confusion; Delirium; Delusions; Depression; Dihyd

1971
Three cases of schizophrenia treated with L-dopa.
    The Kurume medical journal, 1971, Volume: 18, Issue:3

    Topics: Adult; Autistic Disorder; Delusions; Dihydroxyphenylalanine; Drug Synergism; Female; Hallucinations;

1971
Mental complications of L-dopa therapy in Parkinson's patients.
    The Israel annals of psychiatry and related disciplines, 1971, Volume: 9, Issue:3

    Topics: Adult; Aged; Dihydroxyphenylalanine; Drug Antagonism; Female; Humans; Male; Mental Disorders; Middle

1971
Treatment of parkinsonism with L-dopa (study of 105 patients).
    Diseases of the nervous system, 1969, Volume: 30, Issue:11

    Topics: Adolescent; Adult; Age Factors; Aged; Alkaline Phosphatase; Anorexia Nervosa; Aspartate Aminotransfe

1969
[Psychic manifestations during treatment of Parkinson's disease with L-dopa].
    Revue neurologique, 1970, Volume: 122, Issue:2

    Topics: Dihydroxyphenylalanine; Humans; Mental Disorders; Parkinson Disease; Parkinson Disease, Postencephal

1970
Levodopa.
    JAMA, 1970, Dec-14, Volume: 214, Issue:11

    Topics: Age Factors; Dihydroxyphenylalanine; Drug and Narcotic Control; Humans; Intelligence; Intelligence T

1970
L-DOPA in the treatment of depressive symptoms.
    The British journal of psychiatry : the journal of mental science, 1971, Volume: 119, Issue:550

    Topics: Adult; Depression; Dihydroxyphenylalanine; Female; Humans; Male; Mental Disorders; Middle Aged; Remi

1971
Preliminary observations on L-dopa in the treatment of Parkinson's disease.
    The Journal of the Kentucky Medical Association, 1971, Volume: 69, Issue:4

    Topics: Administration, Oral; Adult; Age Factors; Aged; Aspartate Aminotransferases; Dihydroxyphenylalanine;

1971